Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Exforge
Exforge
Novartis to pay $245 mln to end antitrust cases over Exforge drug generics
Novartis to pay $245 mln to end antitrust cases over Exforge drug generics
Reuters
Novartis
generics
antitrust
legal
Exforge
hypertension
Flag link:
5 Blockbuster Drugs Going Off Patent in 2014
5 Blockbuster Drugs Going Off Patent in 2014
Motley Fool
patents
Eli Lilly
Evista
Teva
Copaxone
Novartis
Exforge
Sandostatin LAR
Nexium
AstraZeneca
Flag link:
Top 10 Drug Patent Losses of 2014
Top 10 Drug Patent Losses of 2014
Fierce Pharma
patents
Copaxone
Teva
Nexium
AstraZeneca
Micardis
Boehringer Ingelheim
Sandostatin LAR
Novartis
Exforge
Nasonex
Merck
TriLipix
AbbVie
Evista
Eli Lilly
Restasis
Allergan
Renagel
Sanofi
Flag link:
Novartis says 3 drugs approved in Japan
Novartis says 3 drugs approved in Japan
Yahoo/AP
Japan
Novartis
Equa
Exforge
Afinitor
Flag link:
Novartis Looks at Combination Pills to Fix Hypertension Franchise
Novartis Looks at Combination Pills to Fix Hypertension Franchise
BNET Pharma
hypertension
Novartis
Diovan
Exforge
Flag link:
